Should patients starting biologics be screened for COVID-19?

Ann Rheum Dis. 2022 Aug;81(8):e150. doi: 10.1136/annrheumdis-2020-218437. Epub 2020 Jul 6.
No abstract available

Keywords: antirheumatic agents; autoimmune diseases; biological therapy; immune system diseases; tumor necrosis factor inhibitors.

Publication types

  • Letter
  • Comment

MeSH terms

  • Antirheumatic Agents* / therapeutic use
  • Arthritis, Rheumatoid* / drug therapy
  • Biological Products* / therapeutic use
  • COVID-19*
  • Humans

Substances

  • Antirheumatic Agents
  • Biological Products